These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 23872176

  • 41. Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use.
    Hoang Thi TH, Lhafidi S, Carneiro SP, Flament MP.
    Int J Pharm; 2015 Dec 30; 496(2):842-9. PubMed ID: 26403385
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV, Gu L, Soh JL, Heng PW.
    Pharm Res; 2005 Aug 30; 22(8):1387-98. PubMed ID: 16078149
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
    Krause J, Thommes M, Breitkreutz J.
    Eur J Pharm Biopharm; 2009 Jan 30; 71(1):138-44. PubMed ID: 18805483
    [Abstract] [Full Text] [Related]

  • 47. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S, Newton JM, Bloor JR, Hayes G.
    Int J Pharm; 2002 May 15; 238(1-2):61-76. PubMed ID: 11996811
    [Abstract] [Full Text] [Related]

  • 48. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM, Wartewig S, Füting M, Heilmann A, Neubert RH, Kleinebudde P.
    AAPS PharmSci; 2003 Nov 19; 5(4):E31. PubMed ID: 15198519
    [Abstract] [Full Text] [Related]

  • 49. Analysis of particle kinematics in spheronization via particle image velocimetry.
    Koester M, Thommes M.
    Eur J Pharm Biopharm; 2013 Feb 19; 83(2):307-14. PubMed ID: 23000404
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization.
    Newton JM, Pinto MR, Podczeck F.
    Eur J Pharm Sci; 2007 Mar 19; 30(3-4):333-42. PubMed ID: 17223021
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D, Kleinebudde P.
    Int J Pharm; 2011 May 16; 409(1-2):9-18. PubMed ID: 21335073
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Development of starch-based pellets via extrusion/spheronisation.
    Dukić A, Mens R, Adriaensens P, Foreman P, Gelan J, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2007 Apr 16; 66(1):83-94. PubMed ID: 17045467
    [Abstract] [Full Text] [Related]

  • 58. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR, Agrawal MK, Kumria R.
    Curr Drug Deliv; 2005 Jan 16; 2(1):1-8. PubMed ID: 16305403
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.